Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3033 |
|
Actual shortage: | 243 (8%) | |
Anticipated shortage: | 15 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2766 (91%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
32 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
MYA | 3.00MG 0.02MG | TABLET | Resolved | 2017-03-11 | 2020-09-04 | 555 |
APO-VERAP SR | 120MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2017-03-11 | 2019-12-04 | 552 |
APO-VALSARTAN | 160MG | TABLET | Resolved | 2017-03-11 | 2019-03-08 | 549 |
APO-VALSARTAN/HCTZ | 25MG 160MG | TABLET | Resolved | 2017-03-11 | 2019-03-21 | 546 |
APO-VALGANCICLOVIR | 450MG | TABLET | Actual shortage | 2017-03-11 | 2018-02-21 | 537 |
APO-TRYPTOPHAN | 500MG | CAPSULE | Resolved | 2017-03-11 | 2017-04-12 | 534 |
APO-TRAZODONE TABLETS 50MG | 50MG | TABLET | Resolved | 2017-03-11 | 2017-07-05 | 531 |
APO-TRAVOPROST Z | 0.004% | SOLUTION | Resolved | 2017-03-11 | 2019-01-03 | 528 |
APO-TOLTERODINE | 2MG | TABLET | Resolved | 2017-03-11 | 2018-02-28 | 523 |
APO-TOLTERODINE | 2MG | TABLET | Resolved | 2017-03-11 | 2017-11-07 | 519 |
APO-TOLTERODINE | 1MG | TABLET | Resolved | 2017-03-11 | 2017-11-08 | 516 |
APO-TIMOP | 0.25% | LIQUID | Resolved | 2017-03-11 | 2019-01-03 | 513 |
APO-TIMOP GEL | 0.5% | SOLUTION | Resolved | 2017-03-11 | 2019-02-05 | 510 |
APO-SILDENAFIL R | 20MG | TABLET | Resolved | 2017-03-11 | 2017-08-24 | 507 |
APO-RIZATRIPTAN | 10MG | TABLET | Resolved | 2017-03-11 | 2017-08-18 | 504 |
APO-RIZATRIPTAN RPD | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-03-11 | 2018-09-11 | 493 |
APO-RIZATRIPTAN RPD | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-03-11 | 2020-07-06 | 490 |
APO-RIVASTIGMINE | 4.5MG | CAPSULE | Resolved | 2017-03-11 | 2017-05-18 | 487 |
APO-RISEDRONATE | 150MG | TABLET | Resolved | 2017-03-11 | 2017-03-15 | 484 |
APO-REPAGLINIDE | 2.0MG | TABLET | Resolved | 2017-03-11 | 2018-09-11 | 481 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-TELMISARTAN | 40MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71345 |
APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71342 |
APO-BOSENTAN | 62.5MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71339 |
APO-RIZATRIPTAN RPD | Discontinued | 2019-01-04 | 2019-04-04 | 71334 | ||
APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71237 |
APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71234 |
APO-IRBESARTAN | 75MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71231 |
NAPROXEN SODIUM TABLETS | 220MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71228 |
ACETAMINOPHEN CAPLETS 500 MG | 500MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71225 |
ACETAMINOPHEN CAPLETS 325 MG | 325MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71222 |
ACETAMINOPHEN TABLETS USP 325 MG | 325MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71219 |
ACETAMINOPHEN TABLETS USP 500 MG | 500MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71216 |
APO-LOSARTAN | 100MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71213 |
ACID REDUCER | 150MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71210 |
APO-METFORMIN ER | 500MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2019-01-04 | 2019-01-04 | 71207 |
APO-RABEPRAZOLE | 10MG | TABLET (ENTERIC-COATED) | Discontinued | 2019-01-04 | 2019-01-04 | 71204 |
APO-RABEPRAZOLE | 20MG | TABLET (ENTERIC-COATED) | Discontinued | 2019-01-04 | 2019-01-04 | 71201 |
ACID CONTROL | Discontinued | 2019-01-04 | 2019-01-04 | 71198 | ||
APO-CEFPROZIL | 250MG | TABLET | Discontinued | 2019-01-04 | 2019-02-21 | 71195 |
ACETAMINOPHEN HEADACHE ULTRA RELIEF | 500MG 65MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71192 |